🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to simplify amivantamab intravenous administrat...
Status
Active Not Recruiting
Location
City of Hope Duarte
Start Date
2022-08-05
Trial ID
NCT05388669
This is a Phase 1b study evaluating a combination of PEGPH20 and pembrolizu...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-10-22
Trial ID
NCT02563548
Treatments Being Tested
This study will characterize the movement of drugs within the body, evaluat...
Status
Completed
Location
Local Institution - 0001
Start Date
2019-10-01
Trial ID
NCT04112498
Treatments Being Tested
The purpose of this study is to evaluate consistency of accelerated insulin...
Status
Completed
Location
Profil Institute for Clinical Research
Start Date
2011-12
Trial ID
NCT01526733
Treatments Being Tested
Insulin lispro is approved by the Food and Drug Administration (FDA) for th...
Status
Completed
Location
Barbara Davis Center for Childhood Diabetes
Start Date
2009-05
Trial ID
NCT00883558
Treatments Being Tested
This phase II trial compares the effect of the combination of daratumumab-h...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-26
Trial ID
NCT06948084
The purpose of this study is to determine the maximum tolerated concentrati...
Status
Completed
Location
Healthcare Discoveries, LLC/ICON Development Solutions
Start Date
2008-12
Trial ID
NCT00807963
Treatments Being Tested
The purpose of this study is to assess the anti-tumor activity and safety o...
Status
Recruiting
Location
University of California at San Diego
Start Date
2022-11-11
Trial ID
NCT05498428
The purpose is to evaluate the safety and efficacy as well as the time and ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-05
Trial ID
NCT01120431
Treatments Being Tested
This phase II trial studies how well pembrolizumab and PEGPH20 work in trea...
Status
Withdrawn
Location
M D Anderson Cancer Center
Start Date
2020-02-01
Trial ID
NCT04058964
Treatments Being Tested